✦ LIBER ✦

Prolonged survival in diffuse pleural mesothelioma treated with AU198

✍ Scribed by Ralph Richart; Charles D. Sherman Jr.

Publisher: John Wiley and Sons
Year: 1959
Tongue: English
Weight: 617 KB
Volume: 12
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(195907/08)12:4<799::aid-cncr2820120425>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac abnormalities in patients with d

Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma

✍ Scott Wadler; Dr. Philippe Chahinian; William Slater; Martin Goldman; David Mend 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

Many patients with diffuse malignant pleural mesothelioma have dyspnea or chest pain. Cardiac symptomatology is frequently difficult to differentiate from symptoms of pleuropulmonary disease. To better define the clinical characteristics of cardiac involvement in patients with mesothelioma, the elec

Erlotinib plus bevacizumab in previously

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

✍ David M. Jackman; Hedy L. Kindler; Beow Y. Yeap; Panos Fidias; Ravi Salgia; Joan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

p27kip1 immunoreactivity correlates with

p27kip1 immunoreactivity correlates with long-term survival in pleural malignant mesothelioma

✍ Massimo Bongiovanni; Paola Cassoni; Paolo De Giuli; Laura Viberti; Susanna Cappi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Activity of doxorubicin and cisplatin co

Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II study

✍ A. Ardizzoni; R. Rosso; V. Fusco; M. C. Pennucci; L. Santi; F. Salvati; A. Cinqu 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 3 views

CS-706, a novel cyclooxygenase-2 selecti

CS-706, a novel cyclooxygenase-2 selective inhibitor, prolonged the survival of tumor-bearing mice when treated alone or in combination with anti-tumor chemotherapeutic agents

✍ Michiyo Senzaki; Saori Ishida; Ayumi Yada; Masaharu Hanai; Kosaku Fujiwara; Shin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 176 KB

## Abstract The potent chemopreventive activity of cyclooxygenase‐2 (COX‐2) inhibitors has been demonstrated in a number of preclinical studies, but their potency in antitumor activity is still in dispute. In this report, we demonstrate the potent antitumor activity of a novel COX‐2 inhibitor, CS‐7

High-dose sequential chemotherapy and pe

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma : A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence

✍ Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract ## BACKGROUND The objective of the current study was to evaluate in a multicenter setting the feasibility and efficacy of a high‐dose sequential (HDS) chemotherapy regimen that combined intensive debulking and high‐dose therapy (HDT) with peripheral blood progenitor cell (PBPC) autogra